MGI Tech Launches VisiOmics in Europe and Unveils AI-Enabled Pathology Portfolio at ECP 2026
<p>From Tissue to Answer: Integrated Solutions for Tissue and Molecular Pathology, from multiplex immunofluorescence to sample-to-result sequencing, powered by AI STOCKHOLM, Sept. 15, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company committed to developing core tools and technologies...</p>
Read original article ↗
Related Articles
Fortaegis raises $50M to accelerate deployment of secure compute
The investment will enable the Dutch company to scale production and commercial deployment of its FPGA products across t
No, the EU isn't demanding that Ukraine mobilise women against Russia's invasion
Ukraine's counter-disinformation agency says that the claims originated with Russia's Foreign Intelligence Service.
Caliptra-enabled hardware security solution eyes AI SoCs
The root-of-trust and security orchestration IP for AI SoCs includes a complete hardware-software integration framework.